Table 2 Nerve conduction study variables. Primary endpoint – Primary analysis
Group | n | 10% Improvement for at least 3 motor nerves | Motor Nerve Conduction Velocity (m/s) | Distal Motor Latency (ms) | F Wave Latency (ms) | Duration of the Compound Muscle Action Potential (ms) | Meeting Primary endpoint (change of 2 out of 4 variables) |
|---|---|---|---|---|---|---|---|
All | 15 | No | 13 (87%) | 11 (73%) | 15 (100%) | 11 (73%) | 14 (93%) |
Yes | 2 (13%) | 4 (27%) | 0 | 4 (27%) | 1 (7%) | ||
CIDP | 5 | No | 4 (80%) | 4 (80%) | 5 (100%) | 4 (80%) | 5 (100%) |
Yes | 1 (20%) | 1 (20%) | 0 | 1 (20%) | 0 | ||
anti-MAG | 5 | No | 5 (100%) | 3 (60%) | 5 (100%) | 5 (100%) | 5 (100%) |
Yes | 0 | 2 (40%) | 0 | 0 | 0 | ||
CMT1 | 5 | No | 4 (80%) | 4 (80%) | 5 (100%) | 2 (40%) | 4 (80%) |
Yes | 1 (20%) | 1 (20%) | 0 | 3 (60%) | 1 (20%) |